Nevertheless, suppressing translation of the BDKRB1 gene using RNAi concurrently decreased the bradykinin-triggered invasion by human malignant U87 MG glioblastoma cells (Figure 6F). This evidence concerns the gene BDKRB1 and glioblastoma.